KAS
PJP icon

Kestra Advisory Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Kestra Advisory Services’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,833
Closed -$192K – 4069
2025
Q4 		$192K Buy
+1,833
New +$184K ﹤0.01% 2924
2025
Q2 		– Sell
-1,575
Closed -$136K – 2950
2025
Q1 		$136K Buy
+1,575
New +$134K ﹤0.01% 2550

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kestra Advisory Services's PJP Position: Q1 2026 in Review

Kestra Advisory Services sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2026, closing a stake of 1,833 shares — an estimated $192K sold.

Kestra Advisory Services first reported a position in PJP in Q1 2025 and held it in 2 quarters. The position peaked at $192K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Kestra Advisory Services reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 1,833 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $192K.
  • Kestra Advisory Services first reported a position in Invesco Pharmaceuticals ETF in Q1 2025 and held it in 2 quarters.
  • Kestra Advisory Services's Invesco Pharmaceuticals ETF position peaked at $192K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.